Paper348666
An in vitro model of the urinary bladder.
Greenwood D and 1 other. J Antimicrob Chemother, 1978. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An in vitro model of the urinary bladder. Papers, record 348666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/348666
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Urinary Bladder | Major topic |
| Anti-Bacterial Agents | |
| Bacteria | |
| Bacterial Infections | |
| Culture Media | |
| Drug Interactions | |
| Escherichia coli | |
| Models, Biological | |
| Nephelometry and Turbidimetry | |
| Proteus mirabilis |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,009,754 | Catheter-Associated Urinary Tract Infections: Understanding the Interplay Between Bacterial Biofilm and Antimicrobial Resistance. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009754 | PubMed |
| 39,766,591 | Dynamic In Vitro PK/PD Infection Models for the Development and Optimisation of Antimicrobial Regimens: A Narrative Review. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39766591 | PubMed |
| 39,313,789 | Advances in experimental bladder models: bridging the gap between in vitro and in vivo approaches for investigating urinary tract infections. | BMC Urol | 2024 | https://conductscience.org/library/papers/39313789 | PubMed |
| 36,304,894 | An in vitro bladder model with physiological dynamics: Vesicoureteral reflux alters stent encrustation pattern. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36304894 | PubMed |
| 34,943,697 | Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill Approaches. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34943697 | PubMed |
| 14,742,182 | Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/14742182 | PubMed |
| 7,399,711 | An in vitro model for assessing optimum antibiotic dosage in urinary tract infection. | Infection | 1980 | https://conductscience.org/library/papers/7399711 | PubMed |
| 7,044,399 | Urinary tract infection. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7044399 | PubMed |
| 7,040,252 | Antibacterial kinetics of ampicillin against Escherichia coli under simulated in vivo conditions. | Infection | 1982 | https://conductscience.org/library/papers/7040252 | PubMed |
| 7,028,634 | The antibacterial activity of hexamine (methenamine), hexamine hippurate and hexamine mandelate. | Infection | 1981 | https://conductscience.org/library/papers/7028634 | PubMed |
| 7,019,321 | Factors influencing the establishment and spread of R-plasmids in an experimental model of urinary tract infection. | J Hyg (Lond) | 1981 | https://conductscience.org/library/papers/7019321 | PubMed |
| 6,995,346 | The significance of bacterial kinetic examinations for an adequate dosage of antibiotic. | Infection | 1980 | https://conductscience.org/library/papers/6995346 | PubMed |
| 6,994,635 | Comparison of amoxicillin and ampicillin activities in a continuous culture model of the human urinary bladder. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6994635 | PubMed |
| 6,993,366 | Response of Escherichia coli to Beta-lactam antibiotics: effect of the concomitant presence of staphylococci exhibiting inducible Beta-lactamase activity. | Infection | 1980 | https://conductscience.org/library/papers/6993366 | PubMed |
| 6,489,325 | Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis. | Eur J Clin Microbiol | 1984 | https://conductscience.org/library/papers/6489325 | PubMed |
| 6,402,522 | Semiautomated determination of minimum bactericidal concentrations of antibiotics. | J Clin Pathol | 1983 | https://conductscience.org/library/papers/6402522 | PubMed |
| 6,252,829 | Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6252829 | PubMed |
| 3,980,092 | In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. | Infect Immun | 1985 | https://conductscience.org/library/papers/3980092 | PubMed |
| 3,531,023 | Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis. | Infection | 1986 | https://conductscience.org/library/papers/3531023 | PubMed |
| 3,325,431 | Activity of fosmidomycin in an in vitro model of the treatment of bacterial cystitis. | Infection | 1987 | https://conductscience.org/library/papers/3325431 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/348666
GET https://conductscience.org/api/papers/v1/348666/cited_by?page=2